Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Photocure

Less than 1K followers

PHO

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus

Photocure is a medical technology company. The company specializes in photodynamic technology solutions. The solutions are used to treat diseases that cause bladder cancer and HPV. The main markets are dermatology and oncology, where the products are used by hospitals and research institutes worldwide. The company was founded in 1993 and is headquartered in Oslo, Norway.

Read more
Market cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
All
Press releases
ShowingAll content types
Regulatory press release11/19/2025, 7:00 AM

PHO: New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management

Photocure
Press release11/19/2025, 7:00 AM

Photocure: New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management

Photocure
Regulatory press release10/31/2025, 7:24 AM

Photocure ASA: Notification of primary insider transaction

Photocure

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release10/31/2025, 7:24 AM

Photocure ASA: Notification of primary insider transaction

Photocure
Regulatory press release10/29/2025, 6:00 AM

Photocure ASA: Results for the third quarter of 2025

Photocure
Regulatory press release10/29/2025, 6:00 AM

Photocure ASA: Results for the third quarter of 2025

Photocure
Regulatory press release10/24/2025, 6:20 AM

Photocure ASA: Invitation to presentation of third quarter 2025 financial results

Photocure
Regulatory press release10/24/2025, 6:20 AM

Photocure ASA: Invitation to presentation of third quarter 2025 financial results

Photocure
Regulatory press release10/15/2025, 3:08 PM

PHO: Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy

Photocure
Press release10/15/2025, 3:08 PM

Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy

Photocure
Regulatory press release9/22/2025, 6:23 AM

Photocure ASA - Share option grant

Photocure
Regulatory press release9/22/2025, 6:23 AM

Photocure ASA - Share option grant

Photocure
Regulatory press release8/4/2025, 12:39 PM

Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review

Photocure
Regulatory press release8/4/2025, 12:39 PM

Photocure: Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review

Photocure
Regulatory press release7/30/2025, 5:00 AM

Photocure ASA: Results for the second quarter of 2025

Photocure
Regulatory press release7/30/2025, 5:00 AM

Photocure ASA: Results for the second quarter of 2025

Photocure
Regulatory press release7/22/2025, 6:00 AM

Photocure ASA: Invitation to presentation of second quarter and first half year 2025 financial results

Photocure
Regulatory press release7/22/2025, 6:00 AM

Photocure ASA: Invitation to presentation of second quarter and first half year 2025 financial results

Photocure
Regulatory press release6/23/2025, 12:55 PM

Photocure ASA - Share option grant

Photocure
Regulatory press release6/23/2025, 12:55 PM

Photocure ASA - Share option grant

Photocure
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.